FIBRONECTIN BINDING TO C1Q ASSOCIATED WITH ANTIGEN-ANTIBODY COMPLEXES IN EDTA-TREATED PLASMA

被引:14
作者
SORVILLO, J [1 ]
GIGLI, I [1 ]
PEARLSTEIN, E [1 ]
机构
[1] UNIV CALIF SAN DIEGO,DIV DERMATOL,SAN DIEGO,CA 92103
关键词
D O I
10.1111/j.1365-3083.1986.tb01953.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:153 / 160
页数:8
相关论文
共 37 条
[1]   PLASMA FIBRONECTIN IS A COMPONENT OF CRYOGLOBULINS FROM PATIENTS WITH CONNECTIVE-TISSUE AND OTHER DISEASES [J].
ANDERSON, B ;
RUCKER, M ;
ENTWISTLE, R ;
SCHMID, FR ;
WOOD, GW .
ANNALS OF THE RHEUMATIC DISEASES, 1981, 40 (01) :50-54
[2]   FIBRONECTIN ASSOCIATED WITH CLQ IN A CLQ ISOLATION PROCEDURE [J].
ANDERSON, B ;
ENTWISTLE, R ;
PUYAT, L ;
DAVIS, L ;
SCHMID, FR .
IMMUNOLOGICAL COMMUNICATIONS, 1981, 10 (08) :687-696
[3]   FIBRONECTIN BINDS TO THE CLQ COMPONENT OF COMPLEMENT [J].
BING, DH ;
ALMEDA, S ;
ISLIKER, H ;
LAHAV, J ;
HYNES, RO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (13) :4198-4201
[4]   THE BINDING OF HUMAN-COMPLEMENT COMPONENT-C4 TO ANTIBODY-ANTIGEN AGGREGATES [J].
CAMPBELL, RD ;
DODDS, AW ;
PORTER, RR .
BIOCHEMICAL JOURNAL, 1980, 189 (01) :67-80
[5]   CROSS-LINKING AND BINDING OF FIBRONECTIN WITH ASYMMETRIC ACETYLCHOLINESTERASE [J].
EMMERLING, MR ;
JOHNSON, CD ;
MOSHER, DF ;
LIPTON, BH ;
LILIEN, JE .
BIOCHEMISTRY, 1981, 20 (11) :3242-3247
[6]   BINDING OF SOLUBLE FORM OF FIBROBLAST SURFACE PROTEIN, FIBRONECTIN, TO COLLAGEN [J].
ENGVALL, E ;
RUOSLAHTI, E .
INTERNATIONAL JOURNAL OF CANCER, 1977, 20 (01) :1-5
[7]   THE BINDING OF COMPLEMENT COMPONENT-C3 TO ANTIBODY-ANTIGEN AGGREGATES AFTER ACTIVATION OF THE ALTERNATIVE PATHWAY IN HUMAN-SERUM [J].
GADD, KJ ;
REID, KBM .
BIOCHEMICAL JOURNAL, 1981, 195 (02) :471-480
[8]   UNACTIVATED FORM OF 1ST COMPONENT OF HUMAN COMPLEMENT, C1 [J].
GIGLI, I ;
PORTER, RR ;
SIM, RB .
BIOCHEMICAL JOURNAL, 1976, 157 (03) :541-+
[9]   INTERACTION OF FIBRONECTIN WITH COMPLEMENT COMPONENT-C3 [J].
HAUTANEN, A ;
KESKIOJA, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1983, 17 (03) :225-230
[10]  
HAUTANEN A, 1983, CLIN EXP IMMUNOL, V53, P233